Minimal Requirement for a Lentivirus Vector Based on Human Immunodeficiency Virus Type 1

Abstract excerpt

The use of human immunodeficiency virus vectors for gene therapy is hampered by concern over their safety. This concern might be ameliorated, in part, if the viral accessory genes and proteins could be eliminated from the vector genomes and particles. Here we describe a minimal vector system that is capable of transducing nondividing cells and which does not contain tat, vif, vpr, vpu, and nef.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to HIV Research and Treatment
• Share to Mosquito-borne diseases and control
• Share to Virus-based gene therapy research